PECS I Block for Breast Subpectoral Implant Surgery

• Status: Completed
• Trial end date: 2020-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

Breast augmentation surgery can cause important postoperative pain, especially when bilateral subpectoral implants are used. The investigators hypothesized that a technique of regional analgesia, the pectoral nerve block type I (or "PECS I block") would reduce pain within the first twenty-four hours and, in turn, morphine consumption and associated side effects. This is a randomized, controlled, double-blind study which compares intra and postoperative analgesia with or without PECS I block in breast surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Lille
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• Every female who will benefit of a bilateral subpectoral breast augmentation

• Age more than 18 years

• Social insured

Exclusion Criteria:

• refusal of the patient

• Age less than 18 years

• Inability to consent

• History of thoracic surgery or breast implants

• Pregnancy

• Inability to use a patient controlled analgesia

• Contraindication of the use of opioids or local anesthetics

• Pathology of hemostasis, infection

• Can not use a PCA

• Patients under long-term opioids (WHO pain ladder 2 and 3)

• Patient presenting neuropathic pain during the preoperative period (score greater than or equal to 4 to the DN4 questionnaire, or taking anti-epileptic or antidepressant treatments for neuropathic pain)